세계의 바이오센서 시장 예측(-2030년) : 컴포넌트별, 유형별, 제품별, 기술별, 용도별, 지역별

Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region - Global Forecast to 2030

US $ 4,950 ￦ 6,957,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,346,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,454,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,055,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 바이오센서 시장 규모는 2025년 345억 1,000만 달러에서 2030년까지 543억 7,000만 달러에 달할 것으로 예측되며, 이전 CAGR은 9.5%로 전망되고 있습니다.

신흥 국가에서의 감염병 증가, 신속한 진단 및 효율적인 모니터링 솔루션에 대한 수요 증가, 소형화, 나노테크놀러지, 마이크로플루이딕스공학, 신제품 혁신 등의 기술 발전이 시장 성장의 원동력이 되고 있습니다. 또한 도시 지역에서 수요 증가는 쉽게 구할 수 있고 사용하기 쉬운 진단 장비에 대한 수요 증가로 인해 시장 성장을 더욱 촉진하고 있습니다. 세계 각국 정부는 환자의 자비 부담을 줄이면서 진단 검사의 가용성과 접근성을 보장하기 위해 진단 및 의약품 서비스를 개선하기 위한 구상을 시작하고 있습니다.

조사 범위
조사 대상연도	2021-2030년
기준연도	2024년
예측 기간	2025-2030년
검토 단위	금액(10억 달러)
부문별	컴포넌트별, 유형별, 제품별, 기술별, 용도별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 기타 지역

임베디드 디바이스는 의료, 가정 진단, 식품 및 음료, 실험실, 환경 모니터링, 생물방어 등 다양한 분야에서 널리 사용되고 있습니다. 사물인터넷(IoT) 기기의 성장과 함께 커넥티드 헬스케어에 큰 변화가 일어나고 있으며, IoT는 실시간 경고, 추적, 모니터링, 수작업 치료, 정확도 향상, 의사의 적시 개입, 전반적인 환자 치료 개선 등을 가능하게 합니다. 많은 의료시설에서 원격지의 의사 부족 문제를 해결하기 위해 IoT 기능을 갖춘 의료기기 내장형 솔루션을 채택하기 시작했습니다. 이러한 IoT 지원 의료기기는 원격지에 있는 환자에게 정확하고 신뢰할 수 있는 치료를 제공하기 위해 질병을 식별하고 각종 검사를 수행할 수 있도록 돕습니다. 이에 따라 임베디드 디바이스의 사용이 증가하여 바이오센서 시장 성장을 가속할 것으로 예측됩니다.

비웨어러블 바이오센서 시장은 핸드헬드 툴에서 실험실 시스템 및 현장 진단에 이르기까지 헬스케어, 환경 모니터링, 식품 안전에 필수적인 다양한 용도에 힘입어 성장하고 있는 분야입니다. 병원, 연구, 식품, 환경 분야에서 사용되는 바이오센서는 실시간 현장 모니터링을 통해 식품 품질 문제를 해결하고 안전 기준을 달성할 수 있도록 돕습니다. 시장 성장의 원동력은 환경 모니터링에 대한 인식 증가와 생물학적 방어, 식품 관리, 병원체 검출을 위한 신속한 장비의 필요성입니다.

중국의 바이오센서 시장을 촉진하는 요인으로는 급속한 경제 성장과 고령화, 헬스케어 서비스 개선을 위한 정부의 구상 등이 있습니다. 중국에서 사업을 전개하는 많은 다국적 수출업체와 제조업체들은 신뢰할 수 있는 국내 유통 및 서비스 인프라를 지원하는 인수 및 전략적 제휴 등의 전략을 채택하고 있습니다. 반면, 많은 국내 제조업체, 특히 중국 외 수출 시장에 중점을 둔 제조업체들은 중국내 강력한 유통 및 서비스 네트워크가 부족합니다. 중국은 세계에서 가장 인구가 많은 국가이며, 한 자녀 정책으로 인해 향후 노인 인구가 증가할 것으로 예측됩니다. 고령화에 따라 심장병을 비롯한 각종 질병의 발생률이 크게 증가할 가능성이 높습니다.

세계의 바이오센서 시장에 대해 조사했으며, 컴포넌트별, 유형별, 제품별, 기술별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 밸류체인 분석
• 에코시스템 분석
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 기술 분석
• 사례 연구 분석
• 투자와 자금조달 시나리오
• 생성형 AI/AI가 바이오센서 시장에 미치는 영향
• 특허 분석
• 무역 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 2025-2026년의 주요 컨퍼런스와 이벤트
• 규제 상황과 기준
• 2025년 미국 관세의 영향 - 바이오센서 시장

제6장 바이오센서 시장(컴포넌트별)

• 서론
• 바이오 리셉터 분자
• 생물학적 요소
• 트랜스듀서

제7장 바이오센서 시장(유형별)

• 서론
• 센서 패치
• 임베디드 디바이스

제8장 바이오센서 시장(제품별)

• 서론
• 웨어러블 바이오센서
• 비웨어러블(POC) 바이오센서

제9장 바이오센서 시장(기술별)

• 서론
• 전기화학 바이오센서
• 광학 바이오센서
• 압전 바이오센서
• 열바이오센서
• 나노 메커니컬 바이오센서

제10장 바이오센서 시장(용도별)

• 서론
• POC
• 재택 진단
• 연구실
• 환경 모니터링
• 식품 및 음료
• 바이오 디펜스

제11장 바이오센서 시장(지역별)

• 서론
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 기타
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타
• 기타 지역
  • 남미
  • 중동
  • 아프리카

제12장 경쟁 구도

• 개요
• 주요 참여 기업이 채택하는 전략(2021-2024년)
• 매출 분석, 2022-2024년
• 시장 점유율 분석, 2024년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 기업 평가 매트릭스 : 주요 참여 기업, 2024년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
• 경쟁 시나리오

제13장 기업 개요

• 주요 참여 기업
  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD
  • MEDTRONIC
  • BIO-RAD LABORATORIES, INC.
  • DUPONT
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • CYTIVA
  • DEXCOM, INC.
  • LIFESCAN IP HOLDINGS, LLC
  • MASIMO
  • NOVA BIOMEDICAL
  • UNIVERSAL BIOSENSORS
• 기타 기업
  • ACON LABORATORIES
  • CONDUCTIVE TECHNOLOGIES
  • EASTPRINT INCORPORATED
  • IST AG
  • LIFESIGNALS
  • NEUROSKY
  • PINNACLE TECHNOLOGY
  • SD BIOSENSOR, INC.
  • VITALCONNECT
  • XSENSIO
  • ZIMMER AND PEACOCK
  • PARAGRAF LIMITED
  • DYNAMIC BIOSENSORS
  • LINEXENS
  • BIOLINQ INCORPORATED

제14장 부록

KSA

영문 목차

영문목차

The global biosensors market is expected to reach USD 34.51 billion in 2025 from USD 54.37 billion by 2030, growing at a CAGR of 9.5% during this period. Market growth is driven by the rising number of infectious diseases in developing countries, increasing demand for rapid diagnosis and efficient monitoring solutions, and technological advancements such as miniaturization, nanotechnology, microfluidics, and new product innovations. Additionally, the growing demand in urban areas, where diagnostic devices are easily accessible and simple to use, is further boosting market growth. Governments worldwide are launching initiatives to improve diagnostics and drug services, aiming to ensure availability and access to diagnostic testing while reducing patients' out-of-pocket expenses.

Scope of the Report
Years Considered for the Study	2021-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD Billion)
Segments	By Product, Type, Technology, Application, and Region
Regions covered	North America, Europe, APAC, RoW

"Embedded devices to account for the larger market share in 2030"

Embedded devices are commonly used in various applications such as point of care, home diagnostics, food and beverages, research labs, environmental monitoring, and biodefense. With the growth of the Internet of Things (IoT) devices, there has been a significant shift in connected healthcare applications. IoT enables real-time alerts, tracking, and monitoring, which allows for hands-on treatments, improved accuracy, timely interventions by doctors, and overall better patient care. Many healthcare facilities are beginning to adopt embedded solutions for medical devices with IoT capabilities to address the shortage of doctors in remote areas. These IoT-enabled medical devices help identify diseases and perform various tests to deliver accurate and reliable treatment to patients in remote locations. Consequently, the increasing use of embedded devices will boost the market growth of biosensors.

"Non-wearable (POC) biosensors to capture the largest share of the biosensors market throughout the forecast period"

The non-wearable biosensors market is a vibrant growth area driven by diverse applications, from handheld tools to lab systems and point-of-care diagnostics, vital in healthcare, environmental monitoring, and food safety. These biosensors, used in hospitals, research, food, and environmental sectors, enable real-time, on-site monitoring, helping address food quality challenges and meet safety standards. Market growth is fueled by increased awareness of environmental surveillance and the need for rapid devices for biodefense, food control, and pathogen detection.

"China to hold largest share in Asia Pacific of biosensors market in 2030"

The factors driving the biosensors market in China include rapid economic growth and an aging population, along with government efforts to improve healthcare services. Many multinational exporters and producers operating in China have adopted strategies such as acquisitions or strategic partnerships that support reliable domestic distribution and service infrastructure. In contrast, many domestic manufacturers, particularly those focused on export markets outside of China, lack strong distribution and service networks within the country. China is the most populous country in the world, and with the one-child policy, the elderly population is expected to increase in the future. As the population ages, there will likely be a significant rise in the incidence of various disorders, including heart diseases.

Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows:

• By Company Type: Tier 1-40%, Tier 2-35%, and Tier 3-25%
• By Designation: C-level Executives-45%, Directors-35%, and Others-20%
• By Region: North America-30%, Europe-22%, Asia Pacific-40%, and RoW-8%

Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) are some key players in the biosensors market.

The study includes an in-depth competitive analysis of these key players in the biosensors market, with their company profiles, recent developments, and key market strategies.

Study Coverage: This research report categorizes the biosensors market based on type (sensor patches, embedded devices), product (wearable, non-wearable), technology (electrochemical, optical, piezoelectric, thermal, nanomechanical), component (bioreceptor molecules, biological elements, transducers), application (POC, home diagnostics, research labs, environmental monitoring, food & beverages, biodefense), and region (North America, Europe, Asia Pacific and RoW). The report describes the major drivers, restraints, challenges, and opportunities pertaining to the biosensors market and forecasts the same till 2030. The report also consists of leadership mapping and analysis of all the companies included in the biosensor ecosystem.

Key Benefits of Buying the Report The report will help the market leaders/new entrants in this market by providing information on the closest approximations of the revenue numbers for the overall biosensors market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (emergence of nanotechnology-based biosensors, technological advancements, increasing use of biosensors to monitor glucose levels in individuals with diabetes, government initiatives to support diagnostics) restraints (reluctance to adopt new treatment practices, high costs of R&D), opportunities (emerging markets in developing countries, food & environmental monitoring applications, growth opportunities in wearables) and challenges (regulatory barriers and long certification & approval cycles) influencing the growth of the biosensors market
• Product Development/Innovation: Detailed insights into upcoming technologies, research and development activities, and the latest product and service launches in the biosensors market
• Market Development: Comprehensive information about lucrative markets - the report analyzes the biosensors market across varied regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biosensors market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), and ACON Laboratories (US) in the biosensors market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS & REGIONS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
  • 1.3.4 UNITS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of major secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 List of primary interview participants
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primaries
    • 2.1.2.4 Key industry insights
  • 2.1.3 SECONDARY AND PRIMARY RESEARCH
• 2.2 MARKET SIZE ESTIMATION METHODOLOGY
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
    • 2.2.2.1 Approach to derive market size (supply side)
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET
• 4.2 BIOSENSORS MARKET FOR WEARABLE DEVICES, BY TYPE
• 4.3 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT
• 4.4 BIOSENSORS MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Emergence of nanotechnology-based biosensors
    • 5.2.1.2 Technological advancements in recent years
    • 5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes
    • 5.2.1.4 Supportive government initiatives for diagnostics
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Reluctance to adopt new treatment practices
    • 5.2.2.2 High cost of biosensor R&D
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging markets in developing countries
    • 5.2.3.2 Rising food and environmental monitoring applications
    • 5.2.3.3 Growth opportunities in wearables
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Regulatory barriers and long certification & approval cycles
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.6 PRICING ANALYSIS
  • 5.6.1 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS, BY PRODUCT TYPE, 2025
  • 5.6.2 INDICATIVE SELLING PRICE OF GLUCOSE MONITORING SYSTEMS, BY COMPANY, 2025
  • 5.6.3 INDICATIVE SELLING PRICE TREND OF GLUCOSE MONITORING SYSTEMS, BY REGION
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Multiplexed Biosensors
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 AI-Integrated Biosensing Platforms
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Drug Delivery Systems
• 5.8 CASE STUDY ANALYSIS
  • 5.8.1 CASE STUDY 1: I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER
  • 5.8.2 CASE STUDY 2: INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY
  • 5.8.3 CASE STUDY 3: IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN'S HOSPITAL
  • 5.8.4 CASE STUDY 4: ENABLING SEAMLESS DATA TRANSMISSION FROM PATIENT'S HOME
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 IMPACT OF GEN AI/AI ON BIOSENSORS MARKET
• 5.11 PATENT ANALYSIS
• 5.12 TRADE ANALYSIS
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13.2 THREAT OF SUBSTITUTES
  • 5.13.3 BARGAINING POWER OF BUYERS
  • 5.13.4 BARGAINING POWER OF SUPPLIERS
  • 5.13.5 THREAT OF NEW ENTRANTS
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.16 REGULATORY LANDSCAPE AND STANDARDS
  • 5.16.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16.2 STANDARDS
• 5.17 IMPACT OF 2025 US TARIFFS-BIOSENSORS MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARIFF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 IMPACT ON COUNTRIES/REGIONS
    • 5.17.4.1 US
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 IMPACT ON APPLICATIONS
    • 5.17.5.1 Point of Care (PoC)
    • 5.17.5.2 Home Diagnostics

6 BIOSENSORS MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 BIORECEPTOR MOLECULES
  • 6.2.1 ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS
• 6.3 BIOLOGICAL ELEMENTS
  • 6.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES
• 6.4 TRANSDUCERS
  • 6.4.1 TRANSDUCER CONVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS

7 BIOSENSORS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 SENSOR PATCHES
  • 7.2.1 WIDE-RANGE MONITORING OF VITAL SIGNS AND OTHER REQUIRED PARAMETERS
• 7.3 EMBEDDED DEVICES
  • 7.3.1 BROAD-SPECTRUM DETECTION OF BIOLOGICAL ANALYTES, HIGH SUCCESS RATES IN MEDICAL LABS AND FOOD BIOANALYSES

8 BIOSENSORS MARKET, BY PRODUCT

• 8.1 INTRODUCTION
• 8.2 WEARABLE BIOSENSORS
  • 8.2.1 WRISTWEAR
    • 8.2.1.1 Real-time health and fitness tracking and monitoring
  • 8.2.2 EYEWEAR
    • 8.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years
  • 8.2.3 FOOTWEAR
    • 8.2.3.1 Help in monitoring kilometers run, calories burned, workout hours, blood pressure, and other fitness & health-related data
  • 8.2.4 NECKWEAR
    • 8.2.4.1 Trendy devices that can help monitor fitness and health
  • 8.2.5 BODYWEAR
    • 8.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible
  • 8.2.6 OTHER WEARABLE BIOSENSORS
• 8.3 NON-WEARABLE (POC) BIOSENSORS
  • 8.3.1 REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES

9 BIOSENSORS MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 ELECTROCHEMICAL BIOSENSORS
  • 9.2.1 AMPEROMETRIC SENSORS
    • 9.2.1.1 Blood glucose sensors
      • 9.2.1.1.1 Suitable for medical devices for monitoring blood glucose
  • 9.2.2 POTENTIOMETRIC SENSORS
    • 9.2.2.1 Immunosensors
      • 9.2.2.1.1 Label-free detection and quantification of immune complex
  • 9.2.3 CONDUCTOMETRIC SENSORS
    • 9.2.3.1 Studies in enzymatic reactions and practical applications such as drug and pollutant detection to propel market
• 9.3 OPTICAL BIOSENSORS
  • 9.3.1 SPR BIOSENSORS
    • 9.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels
  • 9.3.2 COLORIMETRIC BIOSENSORS
    • 9.3.2.1 Used in various applications, such as detection and identification of virulence activities
  • 9.3.3 FLUORESCENCE BIOSENSORS
    • 9.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection
• 9.4 PIEZOELECTRIC BIOSENSORS
  • 9.4.1 ACOUSTIC BIOSENSORS
    • 9.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand
  • 9.4.2 MICROCANTILEVER BIOSENSORS
    • 9.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy
• 9.5 THERMAL BIOSENSORS
  • 9.5.1 STABILITY, NO NEED FOR FREQUENT RECALIBRATION, AND INSENSITIVITY TO OPTICAL AND ELECTROCHEMICAL PROPERTIES SUPPORT ADOPTION
• 9.6 NANOMECHANICAL BIOSENSORS
  • 9.6.1 RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES

10 BIOSENSORS MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 POC
  • 10.2.1 GLUCOSE MONITORING
    • 10.2.1.1 Rising prevalence of diabetes, advancements in self-monitoring, and growing awareness about PoC testing
  • 10.2.2 CARDIAC MARKER DETECTION
    • 10.2.2.1 Sedentary urban lifestyles driving prevalence of cardiovascular diseases
  • 10.2.3 INFECTIOUS DISEASE DETECTION
    • 10.2.3.1 Detection of toxins, bacteria, and viruses in physiological and environmental matrices
  • 10.2.4 COAGULATION MONITORING
    • 10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home
  • 10.2.5 PREGNANCY TESTING
    • 10.2.5.1 Growing preference of women for confidentiality and accessibility of test results
  • 10.2.6 BLOOD GAS & ELECTROLYTE DETECTION
    • 10.2.6.1 Growing global aging population to drive market
  • 10.2.7 TUMOR/CANCER MARKER DETECTION
    • 10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research
  • 10.2.8 URINALYSIS TESTING
    • 10.2.8.1 Rising number of urinary tract infections among individuals
  • 10.2.9 CHOLESTEROL TESTING
    • 10.2.9.1 Increasing prevalence of CVDs due to aging and obese population
• 10.3 HOME DIAGNOSTICS
  • 10.3.1 GLUCOSE MONITORING
    • 10.3.1.1 Growing preference for self-monitoring blood glucose devices
  • 10.3.2 PREGNANCY TESTING
    • 10.3.2.1 Need for portable and user-friendly pregnancy testing devices
  • 10.3.3 CHOLESTEROL TESTING
    • 10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals
• 10.4 RESEARCH LABS
  • 10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES
• 10.5 ENVIRONMENTAL MONITORING
  • 10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH
• 10.6 FOOD & BEVERAGES
  • 10.6.1 BIOSENSORS USED FOR PATHOGEN DETECTION TO HELP MEET STRINGENT FOOD STANDARDS
• 10.7 BIODEFENSE
  • 10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE

11 BIOSENSORS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 Availability of and interest in biosensor-based POC to drive market
  • 11.2.2 CANADA
    • 11.2.2.1 Increasing government support to propel market growth
  • 11.2.3 MEXICO
    • 11.2.3.1 Use of biosensors for detecting cardiovascular disorders to propel market growth in Mexico
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Monitoring chronic diseases to escalate biosensors market growth
  • 11.3.2 FRANCE
    • 11.3.2.1 Technological advancements in healthcare systems to drive growth
  • 11.3.3 UK
    • 11.3.3.1 Rising cardiac diseases and aging population to drive market
  • 11.3.4 ITALY
    • 11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications
  • 11.3.5 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Government initiatives for enhancing healthcare products and services to propel market growth
  • 11.4.2 JAPAN
    • 11.4.2.1 Increase in standard of living, rising health awareness, and surge in aging population to support market growth
  • 11.4.3 INDIA
    • 11.4.3.1 Growing population in India to escalate demand for biosensors in healthcare
  • 11.4.4 REST OF ASIA PACIFIC
• 11.5 REST OF THE WORLD
  • 11.5.1 SOUTH AMERICA
    • 11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring
  • 11.5.2 MIDDLE EAST
    • 11.5.2.1 Government and private support to drive adoption of POC testing kits will favor demand for biosensors
    • 11.5.2.2 GCC Countries
      • 11.5.2.2.1 Saudi Arabia
      • 11.5.2.2.2 UAE
      • 11.5.2.2.3 Rest of GCC Countries
    • 11.5.2.3 Rest of Middle East
  • 11.5.3 AFRICA
    • 11.5.3.1 Increasing penetration in consumer electronics and medical devices

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 STRATEGIES ADOPTED BY KEY PLAYERS, 2021-2024
• 12.3 REVENUE ANALYSIS, 2022-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Product footprint
    • 12.7.5.4 Type footprint
    • 12.7.5.5 Technology footprint
    • 12.7.5.6 Application footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ABBOTT LABORATORIES
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product enhancements
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths/Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses/Competitive threats
  • 13.1.2 F. HOFFMANN-LA ROCHE LTD
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths/Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses/Competitive threats
  • 13.1.3 MEDTRONIC
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services/Solutions offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product approvals
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths/Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses/Competitive threats
  • 13.1.4 BIO-RAD LABORATORIES, INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Key strengths/Right to win
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses/Competitive threats
  • 13.1.5 DUPONT
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
      • 13.1.5.3.2 Expansion
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths/Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses/Competitive threats
  • 13.1.6 BIOSENSORS INTERNATIONAL GROUP, LTD.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product approvals
  • 13.1.7 CYTIVA
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 DEXCOM, INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
  • 13.1.9 LIFESCAN IP HOLDINGS, LLC
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
  • 13.1.10 MASIMO
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Deals
  • 13.1.11 NOVA BIOMEDICAL
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 UNIVERSAL BIOSENSORS
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
• 13.2 OTHER PLAYERS
  • 13.2.1 ACON LABORATORIES
  • 13.2.2 CONDUCTIVE TECHNOLOGIES
  • 13.2.3 EASTPRINT INCORPORATED
  • 13.2.4 IST AG
  • 13.2.5 LIFESIGNALS
  • 13.2.6 NEUROSKY
  • 13.2.7 PINNACLE TECHNOLOGY
  • 13.2.8 SD BIOSENSOR, INC.
  • 13.2.9 VITALCONNECT
  • 13.2.10 XSENSIO
  • 13.2.11 ZIMMER AND PEACOCK
  • 13.2.12 PARAGRAF LIMITED
  • 13.2.13 DYNAMIC BIOSENSORS
  • 13.2.14 LINEXENS
  • 13.2.15 BIOLINQ INCORPORATED

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

관련자료